Talia B. Baker, MD (she/her/hers)

Chief of the Division of Transplantation and Advanced Hepatobiliary Surgery
University of Utah, United States

Presentation(s):

• First-Line Therapy Using Yttrium-90 Radioembolization Plus Systemic Gemcitabine, Cisplatin, and Capecitabine for Unresectable Intrahepatic Cholangiocarcinoma

  Monday, April 13, 2026
  3:54 PM - 4:03 PM ET